• 1
    Barrett-Connor E 1995 The economic and human costs of osteoporotic fracture. Am J Med 98: 3S8S.
  • 2
    National Osteoporosis Foundation 2002 America's Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation.
  • 3
    Campion JM, Maricic MJ 2003 Osteoporosis in men. Am Fam Physician 67: 15211526.
  • 4
    Olszynski WP, Shawn Davison K, Adachi JD, Brown JP, Cummings SR, Hanley DA, Harris ST, Hodsman AB, Kendler D, McClung M, Miller PD, Yuen CK 2004 Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment. Clin Ther 26: 1528.
  • 5
    Day JC 1996 Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC: U.S. Government Printing Office.
  • 6
    Ray NF, Chan JK, Thamer M, Melton LJ III 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12: 2435.
  • 7
    Hoerger TJ, Downs KE, Lakshmanan MC, Lindrooth RC, Plouffe L Jr, Wendling B, West SL, Ohsfeldt RL 1999 Healthcare use among U.S. women aged 45 and older: Total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med 8: 10771089.
  • 8
    Chrischilles E, Shireman T, Wallace R 1994 Costs and health effects of osteoporotic fractures. Bone 15: 377386.
  • 9
    Phillips S, Fox N, Jacobs J, Wright WE 1988 The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 9: 271279.
  • 10
    Holbrook TL, Grazier K, Kelsey JL, Stauffer RN 1984. Frequency of Occurence, Impact and Cost of Selected Musculoskeletal Conditions in the United States. Chicago, IL: American Academy of Orthopedic Surgeons.
  • 11
    Tosteson AN, Jonsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD 2001 Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12: 849857.
  • 12
    Grima DT, Burge RT, Becker D, Tosteson AN 2002 Short-term cost-effectiveness of bisphosphonate therapies for post-menopausal osteoporotic women at high risk of fracture. Pharma Therap 27: 448455.
  • 13
    Brecht JG, Kruse HP, Felsenberg D, Mohrke W, Oestreich A, Huppertz E 2003 Pharmacoeconomic analysis of osteoporosis treatment with risedronate. Int J Clin Pharmacol Res 23: 93105.
  • 14
    King AB, Saag KG, Burge RT, Pisu M, Goel N 2005 Fracture reduction affects Medicare economics (FRAME): Impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 16: 15451557.
  • 15
    Melton LJ III, Crowson CS, O'Fallon WM 1999 Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9: 2937.
  • 16
    Nationwide Inpatient Sample 2001 Release 10, Healthcare Cost and Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality.
  • 17
    Arias E 2004 United States life tables, 2001. Natl Vital Stat Rep 52: 138.
  • 18
    National Center for Health Statistics 1998 U.S. Decennial Life Tables for 1989-91, vol II. Hyattsville, MD: National Center for Health Statistics.
  • 19
    U.S. Census Bureau 2004 U.S. interim projections by age, sex, race, and Hispanic origin 2000-2050. Available at Accessed November 28, 2005.
  • 20
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M 2000 Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Miner Res 15: 721739.
  • 21
    U.S. Department of Health and Human Services 2004 Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General.
  • 22
    Osteoporosis 1998 Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 8: S7S80.
  • 23
    U.S. Congress Office of Technical Assistance 1994 Hip fracture outcomes in people age fifty and over. Washington, DC: U.S. Congress Office of Technical Assistance.
  • 24
    Braithwaite RS, Col NF, Wong JB 2003 Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51: 364370.
  • 25
    Grabowski DC, Feng Z, Intrator O, Mor V 2004 Recent trends in state nursing home payment policies. Health Aff (Millwood) W4: 363373.
  • 26
    Burge RT, King AB, Balda E, Worley D 2003 Methodology for estimating current and future burden of osteoporosis in state populations: Application to Florida in 2000 through 2025. Value Health 6: 574583.
  • 27
    Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. JAMA 282: 13441352.
  • 28
    Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11: 8391.
  • 29
    Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR 2000 Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85: 41184124.
  • 30
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 14341441.
  • 31
    Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ 2005 Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: Tropos Study. J Clin Endocrinol Metab 90: 28162822.
  • 32
    Jiang HJ, Andrews R, Stryer D, Friedman B 2005 Racial/ethnic disparities in potentially preventable readmissions: The case of diabetes. Am J Public Health 95: 15611567.
  • 33
    Oparil S, Wright JT Jr 2005 Ethnicity and blood pressure. J Clin Hypertens (Greenwich) 7: 357364.
  • 34
    Saha C, Riner ME, Liu G 2005 Individual and neighborhood-level factors in predicting asthma. Arch Pediatr Adolesc Med 159: 759763.
  • 35
    Hicks LS, Shaykevich S, Bates DW, Ayanian JZ 2005 Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord 5: 16.
  • 36
    U.S. Congress Office of Technology Assessment. 1994 Hip Fracture Outcomes in People Age 50 and Over—Background Paper. Washington, DC: U.S. Government Printing Office.